SHORT MINI-FUTURE - BIOGEN IDEC | Market Closed - Boerse Frankfurt Warrants 11:22:11 16/05/2024 pm IST | ||
| 15 EUR | +4.53% |
|
| Current month | -8.70% | ||
| 1 month | -18.52% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
| Date | Price | Change |
|---|---|---|
| 16/24/16 | 15 | +4.53% |
| 15/24/15 | 14.35 | -7.42% |
| 14/24/14 | 15.5 | -0.26% |
| 13/24/13 | 15.54 | -1.40% |
| 10/24/10 | 15.76 | -0.57% |
Real-time Boerse Frankfurt Warrants
Last update May 16, 2024 at 11:22 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VQ8VD4 |
| ISIN | DE000VQ8VD41 |
| Date issued | 22/06/2021 |
| Strike | 391.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.57 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.67 € |
|---|---|
| Lowest since issue | 1.52 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
230
USD
Average target price
285.9
USD
Spread / Average Target
+24.29%
- Stock Market
- Certificates
- Certificat